日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation

阿仑单抗暴露与T淋巴细胞耗竭:肾移植阿仑单抗诱导治疗的群体药代动力学-药效学模型

van Vugt, Lukas K; Zwart, Tom C; Bezstarosti, Suzanne; Heidt, Sebastiaan; Reinders, Marlies E J; Hesselink, Dennis A; de Vries, Aiko P J; de Winter, Brenda C M; Moes, Dirk Jan A R

Impact of normobaric hyperoxia on finger vasomotor and thermoperceptual responses to local cold in normothermic and mildly hypothermic individuals

常压高氧对体温正常和轻度低温个体手指血管舒缩和局部寒冷温度感知反应的影响

Keramidas, Michail E; Bowes, Heather M; Moes, Maaike I; Eiken, Ola; Gennser, Mikael

Usefulness of the Clinical Frailty Scale in patients with end-stage kidney disease

临床衰弱量表在终末期肾病患者中的应用价值

Lamberink, Kyra; Vermeeren, Yolande M; Moes, Arthur D; Mulderij, Jeanette; Rootjes, Paul A; Zomer, Tizza P

Combining the clinical frailty scale with grip strength for the identification of frailty among end-stage kidney disease patients

将临床衰弱量表与握力相结合,用于识别终末期肾病患者的衰弱情况

Lamberink, Kyra; Rootjes, Paul A; Vermeeren, Yolande M; Moes, Arthur D; Zomer, Tizza P

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?

儿童同种异体干细胞移植中预处理药物的治疗药物监测;我们目前处于什么阶段?

van der Stoep, M Y Eileen C; Oostenbrink, Lisa V E; Bredius, Robbert G M; Moes, Dirk Jan A R; Guchelaar, Henk-Jan; Zwaveling, Juliette; Lankester, Arjan C

Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism

肾移植受者合并 COVID-19 后他克莫司暴露量增加:炎症驱动的代谢下调可能是一种潜在机制

Klomp, Sylvia D; Meziyerh, Soufian; Vissers, Maurits F J M; Moes, Dirk J A R; Arends, Eline J; Teng, Y K Onno; Swen, Jesse J; de Vries, Aiko P J

Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study

人类白细胞抗原筛选的异体间充质干细胞疗法在肾移植中的应用:Neptune 研究,一项 I 期单中心研究

Dreyer, Geertje J; Groeneweg, Koen E; Heidt, Sebastiaan; Roelen, Dave L; van Pel, Melissa; Roelofs, Helene; Huurman, Volkert A L; Bajema, Ingeborg M; Moes, Dirk Jan A R; Fibbe, Willem E; Claas, Frans H J; van Kooten, Cees; Rabelink, Rabelink J; de Fijter, Johan W; Reinders, Marlies E J

A pharmacological rationale for improved everolimus dosing in oncology and transplant patients

改善肿瘤和移植患者依维莫司剂量的药理学原理

Ter Heine, R; van Erp, N P; Guchelaar, H J; de Fijter, J W; Reinders, M E J; van Herpen, C M; Burger, D M; Moes, D J A R

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)

熊去氧胆酸用于预防减肥手术后症状性胆结石疾病:一项随机对照试验的研究方案(UPGRADE试验)

Boerlage, Thomas C C; Haal, Sylke; Maurits de Brauw, L; Acherman, Yair I Z; Bruin, Sjoerd; van de Laar, Arnold W J M; Moes, Daan E; van Wagensveld, Bart A; de Vries, Claire E E; van Veen, Ruben; Schouten, Ruben; Dijkgraaf, Marcel G; Fockens, Paul; Gerdes, Victor E A; Voermans, Rogier P

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

SNAI1 诱导的上皮-间质转化中 miR-661 的表达通过靶向 Nectin-1 和 StarD10 信使促进乳腺癌细胞侵袭

G Vetter, A Saumet, M Moes, L Vallar, A Le Béchec, C Laurini, M Sabbah, K Arar, C Theillet, C-H Lecellier, E Friederich